, 2011 [23] 34 30% 0% 0.273 Ours series

50 29,41% 33,33% 0.14 Figure 1 Fournier’s gangrene with extension to the abdominal wall. Conclusions Fournier’s gangrene is still a very severe disease with a high mortality rate. The advanced age, renal failure on admission, extension of infection to the abdominal wall, occurrence of septic shock and need for postoperative mechanical ventilation are the main prognostic factors of mortality. Early recognition of infection associated with invasive and aggressive treatment is essential for attempting to reduce these prognostic indices. Acknowledgements We would like to thank Dr. Awad Jarar (Colorectal surgery. Cleveland Clinic. OHIO. USA) for his critical revision and help to finalize this work. References 1. Corman JM, Moody JA, Aranson WL: Fournier’s gangrene in a modern surgical setting: improved survival with aggressive management. Br J Urol Int 1999, 84:85–88.CrossRef 2. Morpurgo E, Galandiuk Tariquidar clinical trial S: Fournier’s gangrene. Surg Clin North Am 2002, 82:1213–1224.PubMedCrossRef 3. Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I: Fournier’s gangrene: risk factors and strategies for management. World J Surg 2006, 30:1750–1754.PubMedCrossRef 4. Korkut M, Içöz G, Dayangaç M, Akgün E, Yeniay L, Erdoğan O, Cal C: Outcome

analysis in patients with Fournier’s gangrene: report of 45 cases. Dis Colon Rectum 2003, 46:649–652.PubMedCrossRef 5. Paty R, Smith AD: Gangrene and Fournier’s gangrene. Urol Clin North Am 1992, 19:149–162.PubMed 6. Jeong HJ, Park SC, Seo IY, Rim JS: Prognostic factors in Fournier gangrene. Int J Urol 2005, 12:1041–1044.PubMedCrossRef 7. Yilmazlar T, Ozturk E, Alsoy A, Ozguc H: Necrotizing

SC79 nmr soft tissue infections: APACHE II score, Fossariinae dissemination, and survival. World J Surg 2007, 31:1858–1862.PubMedCrossRef 8. Roghmann F, von Bodman C, Löppenberg B, Hinkel A, Palisaar J, Noldus J: Is there a need for the Fournier’s gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier’s gangrene. BJU Int 2012, 110:1359–1365.PubMedCrossRef 9. Verma S, Sayana A, Kata S, Rai S: Evaluatuion of the utility of the Fournier’s gangrene severity index in the Management of Fournier’s gangrene in North India: A multicentre retrospective Study. J Cutan Aesthet Surg 2012, 5:273–276.PubMedCrossRef 10. Eke N: Fournier’s gangrene: a review of 1726 cases. Br J Surg 2000, 87:718–728.PubMedCrossRef 11. Morua AG, Lopez JA, Temsirolimus chemical structure Garcia JD, Montelongo RM, Guerra LS: Fournier’s gangrene: our experience In 5 Years, bibliographic review and assessment of the Fournier’s gangrene severity index. Arch Esp Urol 2009, 62:532–540.PubMed 12. Sorensen MD, Krieger JN, Rivara FP, Klein MB, Wessells H: Fournier’s gangrene: management and mortality predictors in a population based study. J Urol 2009, 182:2742–2747.PubMedCrossRef 13. Ugwumba FO, Nnabugwu II, Ozoemena OF: Fournier’s Gangrene – Analysis of management and outcome in South-Eastern Nigeria.